Investor Presentaiton

Polo-like kinase-1 identified as a therapeutic target in RDEB CSCC Open ORIGINAL ARTICLE Oncogene (2011) 1 12 ©2011 Macmillan Publishers Limited All rights reserved 0950-9232/11 www.nature.com/onc Integrative mRNA profiling comparing cultured primary cells with clinical samples reveals PLK1 and C20orf20 as therapeutic targets in cutaneous squamous cell carcinoma SA Watt¹³, C Pourreyron¹³, K Purdie², C Hogan', CL Cole¹, N Foster³, N Pratt³, J-C Bourdon¹³, V Appleyard', K Murray', AM Thompson', X Mao², C Mein, L Bruckner-Tuderman³, A Evans, JA McGrath', CM Proby¹, J Foerster', IM Leigh' and AP South' 15 Oncogene. 2011 30(46):4666-77. PMID: 21602893 PMCID: PMC3219832 npg 0 ONCONOVA THERAPEUTICS

View entire presentation